Marshall Wace’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Marshall Wace's PFE Position: Q3 2026 in Review
Marshall Wace increased its Pfizer (PFE) stake by 372% in Q3 2026, buying an estimated $79.5M and bringing the position to 3,790,528 shares worth $108M. The position accounts for 0.09% of the portfolio, ranked #173.
Marshall Wace first reported a position in PFE in Q1 2014 and has held it in 44 quarters since. The position peaked at $452M in Q1 2026. 2,896 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Marshall Wace held 3,790,528 shares of Pfizer worth $108M as of Q3 2026.
- Marshall Wace bought 2,988,132 Pfizer shares in Q3 2026, an estimated $79.5M.
- Pfizer made up 0.09% of Marshall Wace's portfolio in Q3 2026, its #173 holding.
- Marshall Wace first reported a position in Pfizer in Q1 2014 and has held it in 44 quarters since.
- Marshall Wace's Pfizer position peaked at $452M in Q1 2026.
- 2,896 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Marshall Wace's 13F filing for Q3 2026, filed 13 Nov 2026.